Results
Awaiting price reaction for this filing.
Dolphin Medical Services reported Q3 FY26 revenue from operations of Rs. 20.61 lakhs, down from Rs. 24.30 lakhs in Q3 FY25, a YoY decline of about 15%. For the nine months ended December 2025, revenue stood at Rs. 55.81 lakhs versus Rs. 63.59 lakhs in the same period last year, a decline of around 12%. Despite weaker sales, net profit for 9M FY26 rose to Rs. 5.41 lakhs from Rs. 3.62 lakhs, a growth of roughly 49%, helped by lower employee and other expenses. The company had posted a small net loss of Rs. 3.38 lakhs for the full FY25, so it has moved back into profit. The auditor (Kota and Associates) issued a clean limited review report with no qualifications. Notably, reserves remain deeply negative at Rs. (506.04) lakhs as of March 2025, reflecting accumulated losses.
Profitability is improving from a low base, but the shrinking top line and still-negative shareholder reserves remain concerns. For shareholders, the key takeaway is that the company is operational and marginally profitable, though the business remains very small and financially weak overall.